- Home
- ATXS vs FOF Comparison
ATXS vs FOF Comparison
Compare ATXS & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- FOF
- Stock Information
- Founded
- ATXS 2008
- FOF 2006
- Country
- ATXS United States
- FOF United States
- Employees
- ATXS N/A
- FOF N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- FOF Investment Managers
- Sector
- ATXS Health Care
- FOF Finance
- Exchange
- ATXS Nasdaq
- FOF Nasdaq
- Market Cap
- ATXS 401.2M
- FOF 341.7M
- IPO Year
- ATXS 2015
- FOF N/A
- Fundamental
- Price
- ATXS $5.34
- FOF $12.08
- Analyst Decision
- ATXS Strong Buy
- FOF
- Analyst Count
- ATXS 5
- FOF 0
- Target Price
- ATXS $26.60
- FOF N/A
- AVG Volume (30 Days)
- ATXS 276.5K
- FOF 58.7K
- Earning Date
- ATXS 03-11-2025
- FOF 01-01-0001
- Dividend Yield
- ATXS N/A
- FOF 9.07%
- EPS Growth
- ATXS N/A
- FOF N/A
- EPS
- ATXS N/A
- FOF N/A
- Revenue
- ATXS N/A
- FOF N/A
- Revenue This Year
- ATXS N/A
- FOF N/A
- Revenue Next Year
- ATXS N/A
- FOF N/A
- P/E Ratio
- ATXS N/A
- FOF N/A
- Revenue Growth
- ATXS N/A
- FOF N/A
- 52 Week Low
- ATXS $5.29
- FOF $9.59
- 52 Week High
- ATXS $14.04
- FOF $11.75
- Technical
- Relative Strength Index (RSI)
- ATXS 28.85
- FOF 43.64
- Support Level
- ATXS $5.89
- FOF $12.12
- Resistance Level
- ATXS $6.52
- FOF $12.29
- Average True Range (ATR)
- ATXS 0.40
- FOF 0.15
- MACD
- ATXS -0.06
- FOF 0.03
- Stochastic Oscillator
- ATXS 2.50
- FOF 55.32
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.